NWQ Investment Management Company LLC trimmed its stake in Cigna Corporation (NYSE:CI) by 33.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 264,719 shares of the health services provider’s stock after selling 131,141 shares during the period. NWQ Investment Management Company LLC owned about 0.11% of Cigna worth $49,487,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Capstone Investment Advisors Netherlands B.V. bought a new stake in shares of Cigna during the second quarter worth $106,000. Saratoga Research & Investment Management bought a new stake in shares of Cigna during the third quarter worth $112,000. Horan Capital Advisors LLC. bought a new stake in shares of Cigna during the third quarter worth $123,000. Parallel Advisors LLC grew its holdings in shares of Cigna by 62.3% during the second quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock worth $139,000 after purchasing an additional 307 shares during the last quarter. Finally, Acrospire Investment Management LLC grew its holdings in shares of Cigna by 66.7% during the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the health services provider’s stock worth $167,000 after purchasing an additional 400 shares during the last quarter. Hedge funds and other institutional investors own 87.85% of the company’s stock.

In other Cigna news, EVP Alan Muney sold 15,345 shares of the stock in a transaction dated Monday, November 27th. The stock was sold at an average price of $200.80, for a total value of $3,081,276.00. Following the transaction, the executive vice president now owns 28,457 shares of the company’s stock, valued at $5,714,165.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Chairman Isaiah Harris, Jr. sold 247 shares of the stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total value of $45,761.69. The disclosure for this sale can be found here. Insiders have sold 36,203 shares of company stock worth $7,211,251 in the last ninety days. 1.30% of the stock is currently owned by insiders.

Cigna Corporation (NYSE:CI) opened at $204.21 on Thursday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.39 and a current ratio of 0.39. Cigna Corporation has a one year low of $131.03 and a one year high of $212.46. The stock has a market capitalization of $50,325.72, a price-to-earnings ratio of 19.67, a PEG ratio of 1.56 and a beta of 0.50.

Cigna (NYSE:CI) last issued its quarterly earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.36 by $0.47. Cigna had a return on equity of 18.85% and a net margin of 5.74%. The business had revenue of $10.38 billion for the quarter, compared to analyst estimates of $10.17 billion. During the same quarter in the prior year, the firm posted $1.94 earnings per share. The firm’s revenue for the quarter was up 5.1% compared to the same quarter last year. analysts forecast that Cigna Corporation will post 10.34 EPS for the current fiscal year.

Several analysts have recently commented on the company. Piper Jaffray Companies restated a “buy” rating and set a $191.00 target price on shares of Cigna in a report on Sunday, September 17th. BidaskClub upgraded Cigna from a “buy” rating to a “strong-buy” rating in a report on Friday, August 18th. Royal Bank Of Canada restated an “outperform” rating and set a $220.00 target price (up previously from $185.00) on shares of Cigna in a report on Friday, November 3rd. Credit Suisse Group assumed coverage on Cigna in a report on Thursday, November 2nd. They set an “outperform” rating and a $219.00 target price on the stock. Finally, Morgan Stanley increased their target price on Cigna from $188.00 to $195.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. Three analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. Cigna currently has an average rating of “Buy” and a consensus price target of $201.50.

TRADEMARK VIOLATION WARNING: This report was published by Daily Political and is the property of of Daily Political. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://www.dailypolitical.com/2017/12/07/nwq-investment-management-company-llc-has-49-49-million-holdings-in-cigna-corporation-ci.html.

Cigna Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.